18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy-Reference-Cited by-同舟云学术

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy

Published:2010-08 Issue:5 Volume:77 Page:1420-1425
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Schellenberg Devin,Quon Andy,Minn A. Yuriko,Graves Edward E.,Kunz Pamela,Ford James M.,Fisher George A.,Goodman Karyn A.,Koong Albert C.,Chang Daniel T.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference29 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: A Phase I–II study;Brade;Int J Radiat Oncol Biol Phys,2007

3. Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group;J Natl Cancer Inst,1988

4. Eastern Cooperative Oncology Group. ECOG-4201: Phase III randomised study of gemcitabine with or without radiotherapy in patients with locally advanced, unresectable pancreatic cancer. 2008.

5. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group;Moertel;Cancer,1981

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Application of PET/MRI;Radiology‐Nuclear Medicine Diagnostic Imaging;2023-03-10

2. Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy;International Journal of Biological Sciences;2023

3. Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression;Frontiers in Immunology;2022-12-12

4. The Significance of FDG PET/CT–Derived Parameters in Determining Prognosis of Cases with Pancreatic Adenocarcinoma: A Prospective Study;Medicina;2022-08-01

5. Clinical Impact of Dual Time Point 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer;Cancers;2022-07-28